2009
DOI: 10.1111/j.1600-0781.2009.00458.x
|View full text |Cite
|
Sign up to set email alerts
|

Reversal of ultraviolet B‐induced immunosuppression by inhibition of the extracellular signal‐regulated mitogen‐activated protein kinase

Abstract: The ERK1/2 mitogen-activated protein kinase (MAPK) pathway plays an important role in the local UVB-induced immunosuppression, and its specific inhibitor PD can arrest its function, resulting in protection against UVB-induced immunosuppression in the present in vivo study.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

2010
2010
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 44 publications
0
4
0
Order By: Relevance
“…In addition, mitogen-activated protein kinases (MAPKs) regulate key proinflammatory pathways following stimulation with UV and TNF-α (4,5). Three MAPK proteins, i.e., extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK) and p38 MAPK are thought to play different roles in chronic inflammatory diseases and homeostasis in the skin (6)(7)(8).…”
Section: Introductionmentioning
confidence: 99%
“…In addition, mitogen-activated protein kinases (MAPKs) regulate key proinflammatory pathways following stimulation with UV and TNF-α (4,5). Three MAPK proteins, i.e., extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK) and p38 MAPK are thought to play different roles in chronic inflammatory diseases and homeostasis in the skin (6)(7)(8).…”
Section: Introductionmentioning
confidence: 99%
“…MAPK regulate important inflammation pathways following stimulation with UVB irradiation (Carlsen et al, 2004 ; Hong et al, 2009 ; Muthusamy and Piva, 2010 ). UVB radiation exposure can lead to the generation of ROS, which activate various cellular signaling pathways, including the MAPK signaling pathways.…”
Section: Resultsmentioning
confidence: 99%
“…Considering the side effects reported in the clinical trials, topical application of MEK inhibitors is an ideal treatment. So far, MEK inhibitors have been used topically only in mouse models (Jaffee et al, 2000;Leng et al, 2009). We hope safe and effective topical MEK inhibitors for human skin diseases will be developed in the near future.…”
Section: Discussionmentioning
confidence: 99%